HASTINGS DAVID C

CIK 00012374017 companiesNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001237401

Recent Transactions

50 trades

Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2026-01-08+375,000→ 375,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2025-06-26+23,000→ 69,183 total
Award
SCYNEXIS INC$SCYX
Stock Option
2025-06-26+23,000→ 23,000 total
Award
Arbutus Biopharma Corp$ABUS
Common Shares
2025-02-14+90,100→ 249,824 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2025-02-14+365,800→ 365,800 total
Sale
Arbutus Biopharma Corp$ABUS
Common Shares
2025-02-04$3.28/sh−22,183→ 159,724 total
Award
SCYNEXIS INC$SCYX
Stock Option
2024-06-20+23,000→ 23,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2024-06-20+23,000→ 46,183 total
Sale
Arbutus Biopharma Corp$ABUS
Common Shares
2024-02-02$2.31/sh−9,593→ 181,907 total
Award
Arbutus Biopharma Corp$ABUS
Common Shares
2024-02-01+112,500→ 191,500 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2024-02-01+450,000→ 450,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2023-06-15+10,000→ 23,183 total
Award
SCYNEXIS INC$SCYX
Stock Option
2023-06-15+10,000→ 10,000 total
Award
Arbutus Biopharma Corp$ABUS
Common Shares
2023-02-01+79,000→ 79,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2023-02-01+316,000→ 316,000 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Common Stock
2022-07-11$2.20/sh−27,500→ 0 total
Other
Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
2022-07-11−26,583→ 0 total
Other
Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
2022-07-11−11,000→ 0 total
Disposition from Tender
Entasis Therapeutics Holdings Inc.
Common Stock
2022-07-07$2.20/sh−22,000→ 0 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2022-06-17+10,000→ 10,000 total
Award
SCYNEXIS INC$SCYX
Common Stock
2022-06-17+10,000→ 13,183 total
Award
Arbutus Biopharma Corp$ABUS
Stock Option (Right to Buy)
2022-01-20$2.81/sh+285,000→ 285,000 total
Award
Entasis Therapeutics Holdings Inc.
Common Stock
2022-01-18+27,500→ 49,500 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16−7,500→ 0 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16+11,538→ 11,538 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16+5,769→ 5,769 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16−15,000→ 0 total
Disposition to Issuer
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16−12,060→ 0 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2021-07-16+9,276→ 9,276 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2021-06-16+10,000→ 10,000 total
Award
Entasis Therapeutics Holdings Inc.
Common Stock
2021-04-01+22,000→ 22,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2021-02-13+250,000→ 250,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2020-07-06+45,000→ 45,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2020-07-06+55,000→ 55,000 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2020-06-10+11,000→ 11,000 total
Award
Arbutus Biopharma Corp$ABUS
Stock Options
2020-02-17+100,000→ 100,000 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (Right to Buy)
2019-06-19+7,500→ 7,500 total
Award
SCYNEXIS INC$SCYX
Stock Option (Right to Buy)
2019-06-18+45,000→ 45,000 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2019-03-01+137,500→ 137,500 total
Award
Entasis Therapeutics Holdings Inc.
Stock Option (right to buy)
2019-01-18+15,000→ 15,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (right to buy)
2019-01-02+22,500→ 22,500 total
Award
Arbutus Biopharma Corp$ABUS
Employee Stock Option (Right to Buy)
2018-06-19+200,000→ 200,000 total
Purchase
SCYNEXIS INC$SCYX
Common Stock Warrant (right to buy)
2018-03-08+5,325→ 5,325 total
Purchase
SCYNEXIS INC$SCYX
Common Stock
2018-03-08$1.69/sh+11,834→ 31,834 total
Purchase
SCYNEXIS INC$SCYX
Common Stock Warrant (right to buy)
2018-03-08+8,875→ 8,875 total
Award
SCYNEXIS INC$SCYX
Stock Option (right to buy)
2018-01-02+19,989→ 19,989 total
Purchase
SCYNEXIS INC$SCYX
Common Stock
2017-06-21$1.75/sh+20,000→ 20,000 total
Award
Unilife Corp
Stock Option (Right to Buy)
2017-01-26+150,000→ 150,000 total
Award
SCYNEXIS INC$SCYX
Stock Option (right to buy)
2017-01-03+14,499→ 14,499 total
Award
SCYNEXIS INC$SCYX
Stock Option (right to buy)
2016-06-02$3.98/sh+8,800→ 8,800 total

Companies

Recent Filings

Address

C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR

NEW HAVEN, CT, 06510

View on SEC.gov